Cellular and Molecular Mediators of Intestinal Fibrosis.

导出 OA

翻译打印收藏纠错

作者： Ian C,Lawrance ^[1] ; Gerhard,Rogler ^[2] ; Giorgos,Bamias ^[3] ; Christine,Breynaert ^[4] ; Jon,Florholmen ^[5] ; Gianluca,Pellino ^[6] ; Shimon,Reif ^[7] ; Silvia,Speca ^[8] ; Giovanni,Latella ^[9]

作者单位： Centre for Inflammatory Bowel Diseases, Fremantle Hospital, Fremantle, WA, Australia. ^[1] University Department of Medicine and Pharmacology, University of Western Australia, Fremantle Hospital, Freemantle, WA, Australia. ^[2] Division of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland. ^[3] Academic Department of Gastroenterology, Ethnikon and Kapodistriakon University of Athens, Laikon Hospital, Athens, Greece. ^[4] Department of Immunology and Microbiology, Laboratory of Clinical Immunology, KU Leuven, Leuven, Belgium. ^[5] Department of General Internal Medicine, University Hospitals Leuven, Leuven, Belgium. ^[6] Research Group of Gastroenterology and Nutrition, Institute of Clinical Medicine, Artic University of Norway and University Hospital of Northern Norway, Tromsø, Norway. ^[7] General Surgery Unit, Second University of Naples, Naples, Italy. ^[8] Department of Pediatrics, Tel-Aviv Souraski Medical Center, Tel-Aviv, Israel. ^[9] National Institute of Health and Medical Research-INSERM, Unit U995, Lille, France. ^[10] Department of Life, Health and Environmental Sciences, Gastroenterology Unit, University of L'Aquila, L'Aquila, Italy. ^[11]

关键词 chemokine extracellular matrix fibroblast growth factor inflammatory bowel disease interleukin intestinal fibrosis myofibroblast